BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Credit Suisse Downgrades Cadila Healthcare to Sell
Credit Suisse has downgraded Cadila Healthcare to 'underperform' for target price of Rs 360 per share. Credit Suisse says that downgrade is on the back of expensive valuations and upside from clearance of Moraiya facility is already priced in. The brokerage adds that sharp improvement in working capital is temporary and trend of weak sales is likely to continue in India and US.